Lalitpur pharma park: U.P. eyes one lakh crore investment, 1.5 lakh jobs

A pharma park spanning over 2,000 acres is to come up in Lalitpur, which will accommodate up to 70 manufacturing units.

The park is expected to attract an investment of Rs 1 lakh crore into the state, a press statement issued by the state government on Monday read.

This development is expected to generate more than 1.5 lakh job opportunities. Supporting industries related to pharma will indirectly create 3 lakh jobs, the release read further.

The state government will provide 94 plots in the park, in which plots will range from five acres to 50 acres. This includes three plots of 50 acres, five of 30 acres, eight of 20 acres, 15 plots of 15 acres, 20 plots of 10 acres, and 43 plots of five acres each. Out of the total area, the government will provide plots for industry set-ups in 53%, while the remaining portion will be allocated for other facilities, the statement read.

The park will also allocate 60 acres for residential (housing group) and 40 acres for commercial activities.

Ensuring smooth power supply and upgrading the airport is also in the plan. Additionally, a check-dam reservoir and a pumping station will be constructed on the Jamni River at an estimated cost of 60 crore.

Along with this, about 12 types of concessions will be given to the industry to set up plants in UP. These include interest subsidy, SGST refund, exemption from stamp duty and registration charges, electric duty exemption, EPF reimbursement, hire subsidy, air cargo handling subsidy, patent registration subsidy, quality certification subsidy, skill development incentive, and others.

Related Posts

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

On Thursday, Congress workers held protests against the “degrading medical conditions of Rajasthan” and attempted to enter the hospital premises. Rajasthan Health Minister Gajendra Singh Khinvsar’s remarks about women diagnosed…

Price cap on 2 key cancer drugs increased by 50%

NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

Price cap on 2 key cancer drugs increased by 50%

Price cap on 2 key cancer drugs increased by 50%

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case